Toronto Dominion Bank’s Starling Oncology Warrant STLNW Stock Holding History

Toronto Dominion Bank’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.69K	Sell	187,474 -200	-0.1%	-$10	﹤0.01%	2114
2026 Q1	$8.26K	Buy	187,674 +200	+0.1%	+$19	﹤0.01%	1945
2025 Q4	$22.5K	Sell	187,474 -200	-0.1%	-$32	﹤0.01%	1760
2025 Q3	$22.5K	Hold	187,674	–	–	﹤0.01%	1699
2025 Q2	$9.63K	Buy	+187,674	New	+$11.9K	﹤0.01%	1637

Other funds holding STLNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AGM

Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Toronto Dominion Bank's STLNW Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Starling Oncology Warrant (STLNW) stake by 0.11% in Q2 2026, selling an estimated $10 and leaving 187,474 shares worth $7.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Toronto Dominion Bank first reported a position in STLNW in Q2 2025 and has held it in 5 quarters since. The position peaked at $22.5K in Q3 2025. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.

Toronto Dominion Bank held 187,474 shares of Starling Oncology Warrant worth $7.69K as of Q2 2026.
Toronto Dominion Bank sold 200 Starling Oncology Warrant shares in Q2 2026, an estimated $10.
Starling Oncology Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2114 holding.
Toronto Dominion Bank first reported a position in Starling Oncology Warrant in Q2 2025 and has held it in 5 quarters since.
Toronto Dominion Bank's Starling Oncology Warrant position peaked at $22.5K in Q3 2025.
12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.